NIF Ventures

Tolerx develops novel therapies that modulate T-cell activities to treat patients with autoimmune diseases, diabetes and cancer.

Voice and Video service management

Intercytex Group is a biotechnology company developing cell-based therapies for the repair and regeneration of skin and hair.

Elixent supplies reconfigurable arithmetic processors which offer reconfigurable semiconductor intellectual property in the U.K.

Tolerx develops novel therapies that modulate T-cell activities to treat patients with autoimmune diseases, diabetes and cancer.

TorreyPines Therapeutics engages in the discovery and development of small molecule compounds in the United States.

Escend Technologies offers design-win tracking and management software for semiconductor and electronic component manufacturers.

BioXell is a biomedical research institute focusing on chronic inflammatory disease and autoimmunity.

Voice and Video service management

Plexxikon is a engages in the discovery and development of small molecule pharmaceuticals to treat human disease.